DE60023720D1 - Zusammensetzung für inhalierung enthaltend delta-9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel - Google Patents

Zusammensetzung für inhalierung enthaltend delta-9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel

Info

Publication number
DE60023720D1
DE60023720D1 DE60023720T DE60023720T DE60023720D1 DE 60023720 D1 DE60023720 D1 DE 60023720D1 DE 60023720 T DE60023720 T DE 60023720T DE 60023720 T DE60023720 T DE 60023720T DE 60023720 D1 DE60023720 D1 DE 60023720D1
Authority
DE
Germany
Prior art keywords
tetrahydrocannabinol
semi
aqueous solvent
delta
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60023720T
Other languages
English (en)
Other versions
DE60023720T2 (de
Inventor
M Mcphillips
J Economou
G Dedhiya
Ann Wynne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unimed Pharmaceuticals LLC
Original Assignee
Unimed Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unimed Pharmaceuticals LLC filed Critical Unimed Pharmaceuticals LLC
Application granted granted Critical
Publication of DE60023720D1 publication Critical patent/DE60023720D1/de
Publication of DE60023720T2 publication Critical patent/DE60023720T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DE60023720T 1999-08-20 2000-08-15 Zusammensetzung für inhalierung enthaltend delta-9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel Expired - Lifetime DE60023720T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15002399P 1999-08-20 1999-08-20
US150023P 1999-08-20
PCT/US2000/022495 WO2001013886A1 (en) 1999-08-20 2000-08-15 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent

Publications (2)

Publication Number Publication Date
DE60023720D1 true DE60023720D1 (de) 2005-12-08
DE60023720T2 DE60023720T2 (de) 2006-07-20

Family

ID=22532791

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60023720T Expired - Lifetime DE60023720T2 (de) 1999-08-20 2000-08-15 Zusammensetzung für inhalierung enthaltend delta-9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel

Country Status (15)

Country Link
EP (1) EP1212039B1 (de)
JP (1) JP2003535813A (de)
CN (1) CN1187093C (de)
AT (1) ATE308314T1 (de)
AU (1) AU779324B2 (de)
CA (1) CA2382217A1 (de)
DE (1) DE60023720T2 (de)
DK (1) DK1212039T3 (de)
ES (1) ES2246883T3 (de)
HK (1) HK1056318A1 (de)
IL (2) IL148241A0 (de)
MX (1) MXPA02001804A (de)
NO (1) NO20020835L (de)
NZ (1) NZ517517A (de)
WO (1) WO2001013886A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6747058B1 (en) 1999-08-20 2004-06-08 Unimed Pharmaceuticals, Inc. Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
US7648696B2 (en) 1999-08-20 2010-01-19 Unimed Pharmaceuticals, Llc Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
WO2001066089A2 (en) 2000-03-09 2001-09-13 Gw Pharma Limited Pharmaceutical compositions comprising cannabis
GB2361869B (en) * 2000-03-09 2004-09-22 Pharmasol Ltd Sublingual delivery of cannabis
MXPA05001567A (es) * 2002-08-14 2005-04-25 Gw Pharma Ltd Formulaciones liquidas de canabinoides para la administracion a traves de la mucosa.
GB2392093B (en) * 2002-08-14 2006-03-08 Gw Pharma Ltd Pharmaceutical formulations
US7674922B2 (en) 2005-09-29 2010-03-09 Albany Molecular Research, Inc. Process for production of delta-9-tetrahydrocannabinol
GB2431105A (en) 2005-10-12 2007-04-18 Gw Pharma Ltd Cannabinoids for the treatment of pulmonary disorders
GB2524469A (en) * 2014-02-14 2015-09-30 Kind Consumer Ltd A cannabinoid inhaler and composition therefor
US9918961B2 (en) 2014-02-19 2018-03-20 Kind Consumer Limited Cannabinoid inhaler and composition therefor
US11911361B2 (en) 2014-05-29 2024-02-27 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
IL249197B2 (en) * 2014-05-29 2024-09-01 Insys Pharma Inc Stable cannabinoid formulations
US11331279B2 (en) 2014-05-29 2022-05-17 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
CA2952934A1 (en) 2014-06-26 2015-12-30 Island Breeze Systems Ca, Llc Mdi related products and methods of use
CN110200953B (zh) * 2019-06-15 2022-02-08 汉义生物科技（北京）有限公司 大麻素在制备吸入给药药物中的应用
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler

Also Published As

Publication number Publication date
NO20020835D0 (no) 2002-02-20
HK1056318A1 (en) 2004-02-13
IL148241A (en) 2007-02-11
CN1420761A (zh) 2003-05-28
DE60023720T2 (de) 2006-07-20
NZ517517A (en) 2004-03-26
EP1212039B1 (de) 2005-11-02
CA2382217A1 (en) 2001-03-01
WO2001013886A1 (en) 2001-03-01
AU779324B2 (en) 2005-01-20
DK1212039T3 (da) 2005-12-19
MXPA02001804A (es) 2004-09-06
ATE308314T1 (de) 2005-11-15
ES2246883T3 (es) 2006-03-01
NO20020835L (no) 2002-04-02
CN1187093C (zh) 2005-02-02
IL148241A0 (en) 2002-09-12
JP2003535813A (ja) 2003-12-02
EP1212039A1 (de) 2002-06-12
AU6910700A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
DE60023720D1 (de) Zusammensetzung für inhalierung enthaltend delta-9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel
CY1120513T1 (el) Υψηλης συμπυκνωσης συνθεση μινοξιδιλης
US4912124A (en) Antifungal dermatological solution
ES2120247T3 (es) Soluciones estables de budesonida, procedimiento para su preparacion, asi como empleo de estas soluciones como preparados para enemas y espumas farmaceuticas.
FI971776A (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
FI934000A (fi) Nya estrar av bi- och tricykliska aminoalkoholer, deras framstaellning och deras anvaendning i laekemedel
AR008927A1 (es) Una composicion farmaceutica que comprende una sustancia medicinalmente activa insoluble en agua con propiedades mejoradas de disolucion, absorcion, etc., y el procedimiento para prepararla
EA200702593A1 (ru) Высококонцентрированные композиции, применимые для борьбы с экто- и эндопаразитами
AR085989A2 (es) Composiciones endoparasiticidas y proceso para su preparacion
MY101536A (en) Anti-inflammatory and analgesic tape for external use
WO2005025500A3 (en) Process for preparing water soluble diterpenes and their applications
KR850004389A (ko) 경피침투가 증진된 생리학적 활성제제의 제조방법
HUT67661A (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
ATE228005T1 (de) Pharmazeutische formulierungen aus corticotropin freisetzenden faktor mit verbesserter stabilitaet in fluessiger form
ES2171525T3 (es) Composiciones farmaceuticas para uso topico conteniendo acido (s)-2-(4-isobutilfenil)propionico.
PE20040303A1 (es) Formulacion parenteral liquida estable de parecoxib
ES2174388T3 (es) Solucion liquida de medicamento para administracion oral.
KR910005869A (ko) 한개 이상의 에틸렌이민기를 가지는 항신생 화합물에 대한 안정한, 주입 가능한 제약학적 조성물 및 그의 제조 방법
ATE14437T1 (de) Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel.
ATE1442T1 (de) Pharmazeutisches mittel, enthaltend all-e- oder 13-z-7,8-dehydro-retinsaeure und verfahren zu seiner herstellung.
SE9902742D0 (sv) New pharmaceutical formultion
CO4370014A1 (es) Soluciones inyectables estables de diritromicina
US4089968A (en) Stable solutions of ipronidazole
EP0156508A1 (de) Fungizide Aerosol-Lösung
Ya'E et al. The effect and mechanism of new natural miticide camphor oil in killing Demodex

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: UNIMED PHARMACEUTICALS, INC., MARIETTA, GA., US

8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1212039

Country of ref document: EP

Representative=s name: LUTZ WERNER BAURIEGEL, 30173 HANNOVER, DE